2026-06-09
What If Female Immunity Should Be Studied Across the Entire Lifespan?
Allergology and Immunology
By Ana Espino | Published on June 09, 2026 | 4 min read
Differences between women and men in their responses to infections, autoimmune diseases, and vaccines have long been recognized. Women generally develop stronger immune responses than men, which may provide better protection against certain infections but also increase their susceptibility to autoimmune diseases.
However, most scientific studies continue to examine these differences through a relatively static lens, simply comparing males and females. This approach overlooks a critical factor: female immunity continuously evolves throughout life under the influence of major hormonal transitions such as puberty, pregnancy, and menopause.
In an editorial published in Biology of Sex Differences in 2026, American researchers propose rethinking the study of immune differences through a life-course approach, which considers all stages of life. Their objective is to demonstrate that age and biological transitions are major determinants of immune function and should be systematically integrated into both research and clinical practice.
The authors draw on a wide range of existing immunological evidence to illustrate how major biological transitions influence immune system function.
During puberty, hormonal changes contribute to immune maturation and coincide with the emergence of certain autoimmune diseases. Throughout the reproductive years, women often exhibit stronger vaccine responses but also a higher prevalence of autoimmune disorders.
Pregnancy represents a particularly unique period. The immune system must achieve a delicate balance between tolerating the fetus and maintaining protection against infectious agents. This adaptation can alter susceptibility to infections as well as the course of certain autoimmune diseases. Following childbirth, an “immune rebound” is frequently observed.
Perimenopause and menopause are associated with a progressive decline in sex hormones, accompanied by inflammatory, metabolic, and immunological changes. Finally, aging is characterized by immunosenescence, including reduced vaccine effectiveness and increased vulnerability to chronic diseases. The framework presented by the authors clearly illustrates this gradual evolution of female immunity across the lifespan.
Read next : Asthma: men and women, the same disease?
The authors emphasize that failing to account for these biological stages currently limits our understanding of immune mechanisms. They note, for example, that nearly 80% of patients with autoimmune diseases are women, and that responses to infections and vaccines often vary according to both sex and age.
They therefore advocate for studies that incorporate factors such as hormonal status, reproductive history, pregnancy, menopause, and environmental exposures throughout life. Such an approach would provide data that more accurately reflect biological reality and could improve the precision of prevention strategies, vaccination programs, and therapeutic interventions.
Read next : Sharing the contraceptive burden: men step into the game
This article does not present new experimental findings but rather proposes a paradigm shift in the way immune differences between sexes are studied. The authors argue that female immunity cannot be fully understood through a simple male-versus-female comparison conducted at a single point in time.
They also acknowledge that available data remain fragmented for certain life stages, particularly pregnancy, breastfeeding, and menopause, which have historically been underrepresented in clinical research.
According to the authors, systematically integrating a life-course perspective into future studies could improve our understanding of immune-mediated diseases, help reduce certain health inequalities, and support the development of more personalized therapeutic approaches for women.
About the author – Ana Espino
PhD in Immunology, specialized in Virology
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions.
Differences between women and men in their responses to infections, autoimmune diseases, and vaccines have long been recognized. Women generally develop stronger immune responses than men, which may provide better protection against certain infections but also increase their susceptibility to autoimmune diseases.
However, most scientific studies continue to examine these differences through a relatively static lens, simply comparing males and females. This approach overlooks a critical factor: female immunity continuously evolves throughout life under the influence of major hormonal transitions such as puberty, pregnancy, and menopause.
In an editorial published in Biology of Sex Differences in 2026, American researchers propose rethinking the study of immune differences through a life-course approach, which considers all stages of life. Their objective is to demonstrate that age and biological transitions are major determinants of immune function and should be systematically integrated into both research and clinical practice.
An Immune System That Changes at Every Stage of Life
The authors draw on a wide range of existing immunological evidence to illustrate how major biological transitions influence immune system function.
During puberty, hormonal changes contribute to immune maturation and coincide with the emergence of certain autoimmune diseases. Throughout the reproductive years, women often exhibit stronger vaccine responses but also a higher prevalence of autoimmune disorders.
Pregnancy represents a particularly unique period. The immune system must achieve a delicate balance between tolerating the fetus and maintaining protection against infectious agents. This adaptation can alter susceptibility to infections as well as the course of certain autoimmune diseases. Following childbirth, an “immune rebound” is frequently observed.
Perimenopause and menopause are associated with a progressive decline in sex hormones, accompanied by inflammatory, metabolic, and immunological changes. Finally, aging is characterized by immunosenescence, including reduced vaccine effectiveness and increased vulnerability to chronic diseases. The framework presented by the authors clearly illustrates this gradual evolution of female immunity across the lifespan.
Read next : Asthma: men and women, the same disease?
Rethinking Research to Better Understand Women’s Health
The authors emphasize that failing to account for these biological stages currently limits our understanding of immune mechanisms. They note, for example, that nearly 80% of patients with autoimmune diseases are women, and that responses to infections and vaccines often vary according to both sex and age.
They therefore advocate for studies that incorporate factors such as hormonal status, reproductive history, pregnancy, menopause, and environmental exposures throughout life. Such an approach would provide data that more accurately reflect biological reality and could improve the precision of prevention strategies, vaccination programs, and therapeutic interventions.
Read next : Sharing the contraceptive burden: men step into the game
A New Way of Thinking About Immunology
This article does not present new experimental findings but rather proposes a paradigm shift in the way immune differences between sexes are studied. The authors argue that female immunity cannot be fully understood through a simple male-versus-female comparison conducted at a single point in time.
They also acknowledge that available data remain fragmented for certain life stages, particularly pregnancy, breastfeeding, and menopause, which have historically been underrepresented in clinical research.
According to the authors, systematically integrating a life-course perspective into future studies could improve our understanding of immune-mediated diseases, help reduce certain health inequalities, and support the development of more personalized therapeutic approaches for women.
About the author – Ana Espino
PhD in Immunology, specialized in Virology
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions.
Last press reviews
What If Female Immunity Should Be Studied Across the Entire Lifespan?
By Ana Espino | Published on June 09, 2026 | 4 min read<br>
GLP-1 Analogues and Polycystic Ovary Syndrome: A New Approach Beyond Weight Loss?
By Ana Espino | Published on June 08, 2026 | 4 min read<br><br><br>P...
Andes Hantavirus: The Next Virus to Watch Closely?
By Ana Espino | Published on June 08, 2026 | 4 min read<br><br><br>